Immune camouflage: Relevance to vaccines and human immunology

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 12, 2014, Pages 3570-3575

  De Groot, Anne S ^a,b   Moise, Lenny ^a   Liu, Rui ^b   Gutierrez, Andres H ^b   Tassone, Ryan ^b   Bailey Kellogg, Chris ^c   Martin, William ^a  

^a EpiVax Inc   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c DARTMOUTH COLLEGE   (United States)

Author keywords

Biologic; Deimmunization; EpiMatrix; JanusMatrix; Tolerance; Treg; Tregitope; Vaccine

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TREGITOPE; UNCLASSIFIED DRUG; VACCINE; VIRUS ENVELOPE PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBODY AFFINITY; ANTIBODY TITER; ANTIGEN PRESENTING CELL; CROSS REACTION; DRUG DESIGN; EPITOPE MAPPING; HEPATITIS C VIRUS; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE CAMOUFLAGE; IMMUNE EVASION; IMMUNOGENICITY; IMMUNOLOGY; INFLUENZA VIRUS A H7N9; INNATE IMMUNITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS GENOME; IMMUNOLOGICAL TOLERANCE; INFLUENZA A VIRUS (H7N9); PHYSIOLOGY;

CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; INFLUENZA A VIRUS, H7N9 SUBTYPE; RECEPTORS, ANTIGEN, T-CELL; VACCINES;

EID: 84922582814     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.36134     Document Type: Review

References (39)

1. De Groot AS, Ardito M, Terry F, Levitz L, Ross T, Moise L, Martin B. Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design. Hum Vaccin Immunother 2013; 9 (5):950-6; PMID:23807079; http://dx.doi.org/10.4161/hv.24939
2. De Groot AS, Moise L, Liu R, Gutierrez AH, Terry F, Koita OA, Ross TM, Martin W. Cross-conservation of T-cell epitopes: now even more relevant to [H7N9] influenza vaccine design. Hum Vaccin Immunother 2014; 10(2):256-62; PMID:24525618; http://dx.doi.org/10.4161/hv.28135
3. Moise L, Cousens L, Fueyo J, De Groot AS. Harnessing the power of genomics and immunoinformatics to produce improved vaccines. Expert Opin Drug Discov 2011; 6(1):9-15; PMID:22646824; http://dx.doi.org/10.1517/17460441.2011.534454
4. Zhang S, Desrosiers J, Aponte-Pieras JR, DaSilva K, Fast LD, Terry F, Martin WD, De Groot AS, Moise L, Moss S. Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods. PLoS One 2014; 9(4):e94974; PMID:24740005; http://dx.doi.org/10.1371/journal. pone.0094974
5. Mishra S, Losikoff PT, Self AA, Terry F, Ardito MT, Tassone R, Martin WD, De Groot AS, Gregory SH. Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells. Vaccine 2014; 32(26):3285-92; PMID:24721533; http://dx.doi.org/10.1016/j.vaccine.2014.03.083
6. Novartis announces positive clinical trial results for novel H7N9 vaccine. Media Release on Novartis Website [Internet] 2013 [cited 2014 Jul 28]; Available from: http://www.novartis.com/newsroom/media-releases/en/2013/1743124.shtml
7. Fries LF, Smith GE, Glenn GM. (NovaVax) A recombinant viruslike particle influenza A (H7N9) vaccine. N Engl J Med 2013; 369(26):2564-6; PMID:24224560; http://dx.doi.org/10.1056/NEJMc1313186
8. Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 US communities. PLoS One 2011; 6(8):e23085; PMID:21857999; http://dx.doi.org/10.1371/journal.pone.0023085
9. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep 2013; 62(RR-07):1-43
10. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 2006; 24(8):1159-69; PMID:16213065; http://dx.doi.org/10.1016/j.vaccine. 2005.08.105
11. Guo L, Zhang X, Ren L, Yu X, Chen L, Zhou H, Gao X, Teng Z, Li J, Hu J et al. Human antibody responses to avian influenza A(H7N9) virus, 2013. Emerg Infect Dis 2014; 20(2):192-200; PMID:24447423; http://dx.doi.org/10.3201/eid2002.131094
12. He L, De Groot AS, Gutierrez AH, Martin WD, Moise L, Bailey-Kellogg C. Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage. BMC Bioinformatics 2014; 15(Suppl 4):S1; PMID:25104221; http://dx.doi.org/10.1186/1471-2105-15-S4-S1
13. Rosenblum MD, Gratz IK, Paw JS, Lee K, Marshak-Rothstein A, Abbas AK. Response to self antigen imprints regulatory memory in tissues. Nature 2011; 480(7378):538-42; PMID:22121024
14. De Groot AS, Terry F, Cousens L, Martin W. Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics. Expert Rev Clin Pharmacol 2013; 6(6):651-62; PMID:24164613; http://dx.doi.org/10.1586/17512433.2013.835698
15. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF. Tumor-specific human CD4C regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004; 20(1):107-18; PMID:14738769; http://dx.doi.org/10.1016/S1074-7613(03)00359-5
16. Dubin G, Koziel J, Pyrc K, Wladyka B, Potempa J. Bacterial proteases in disease-role in intracellular survival, evasion of coagulation/fibrinolysis innate defenses, toxicoses and viral infections. Curr Pharm Des 2013; 19(6):1090-113; PMID:23016681; http://dx.doi.org/10.2174/1381612811319060011
17. Sin SH, Dittmer DP. Cytokine homologs of human gamma herpes viruses. J Interferon Cytokine Res 2012; 32(2):53-9; PMID:22142220; http://dx.doi.org/10.1089/jir.2011.0083
18. Jongerius I, Ram S, Rooijakkers S. Bacterial complement escape. Adv Exp Med Biol 2009; 666:32-48; PMID:20054973; http://dx.doi.org/10.1007/978-1-4419-1601-3-3
19. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004; 199(5):687-95; PMID:14993252; http://dx.doi.org/10.1084/jem.20031636
20. Genestet C, Le Gouellec A, Chaker H, Polack B, Guery B, Toussaint B, Stasia MJ. Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing. Free Radic Biol Med 2014; 73C:400-410; http://dx.doi.org/10.1016/j.freeradbiomed.2014.06.003
21. Lappann M, Danhof S, Guenther F, Olivares-Florez S, Mordhorst IL, Vogel U. In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. Mol Microbiol 2013; 89(3):433-49; PMID:23750848; http://dx.doi.org/10.1111/mmi. 12288
22. Malachowa N, Kobayashi SD, Freedman B, Dorward DW, DeLeo FR. Staphylococcus aureus leukotoxin GH promotes formation of neutrophil extracellular traps. J Immunol 2013; 191(12):6022-9; PMID:24190656; http://dx.doi.org/10.4049/jimmunol. 1301821
23. Larrubia JR, Moreno-Cubero E, Lokhande MU, García-Garzón S, Lázaro A, Miquel J, Perna C, Sanzde-Villalobos E. Adaptive immune response during hepatitis C virus infection. World J Gastroenterol 2014; 20(13):3418-30; PMID:24707125; http://dx.doi.org/10.3748/wjg.v20.i13.3418
24. Song H, Pavlicek JW, Cai F, Bhattacharya T, Li H, Iyer SS, Bar KJ, Decker JM, Goonetilleke N, Liu MK et al. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome. Retrovirology 2012; 9:89; PMID:23110705; http://dx.doi.org/10.1186/1742-4690-9-89
25. Vider-Shalit T, Sarid R, Maman K, Tsaban L, Levi R, Louzoun Y. Viruses selectively mutate their CD8C Tcell epitopes-a large-scale immunomic analysis. Bioinformatics 2009; 25(12):i39-44; PMID:19478014; http://dx.doi.org/10.1093/bioinformatics/btp221
26. Maman Y, Nir-Paz R, Louzoun Y. Bacteria modulate the CD8C T cell epitope repertoire of host cytosolexposed proteins to manipulate the host immune response. PLoS Comput Biol 2011; 7(10):e1002220; http://dx.doi.org/10.1371/journal.pcbi.1002220
27. Jawa V, Cousens LP, Awwad M, Wakshull E, Kropshofer H, De Groot AS. T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation. Clin Immunol 2013; 149 (3):534-55; PMID:24263283; http://dx.doi.org/10.1016/j.clim.2013.09.006
28. De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P, Scott DW, Martin W. Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes." Blood 2008; 112(8):3303-11; PMID:18660382; http://dx.doi.org/10.1182/blood-2008-02-138073
29. Cousens LA, De Groot AS, Najafian, N, Martin WD. Tregitopes: An Immunomodulation Powerhouse, Hum Immunol. 2014 Dec;75(12):1139-46. doi: 10.1016/j.humimm.2014.10.012. PMID: 25454619
30. De Groot AS, Cousens L, Mingozzi F, Martin W. Tregitope peptides: the active pharmaceutical ingredient of IVIG? Clin Dev Immunol 2013; 2013:493138; PMID:24454476; http://dx.doi.org/10.1155/2013/493138
31. Moise L, Gutierrez AH, Bailey-Kellogg C, Terry F, Leng Q, Abdel Hady KM, Verberkmoes N, Sztein MB, Losikoff P, Martin WD et al., Rothman A, De Groot AS. The two-faced T cell epitope: examining the hostmicrobe interface with JanusMatrix. Hum Vaccin Immunother 2013; 9(7) 1577-86; PMID:23584251; http://dx.doi.org/10.4161/hv.24615
32. Liu R, Moise L, Sangare K, Desrosiers J, Martin W, De Groot AS. Immunogenicity of Teffector and Treg epitopes from H7N9 avian-origin influenza: impact of cross-reactivity with the human genome. J Immunol 2014; 192(1) Suppl: 72.12; http://dx.doi.org/10.4049/jimmunol.1301513
33. Losikoff PT, Self AA, Gregory SH. Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. Virulence 2012; 3(7):610-20; PMID:23076334; http://dx.doi.org/10.4161/viru.21823
34. Losikoff PT, Mishra S, Terry F, Gutierrez A, Ardito MT, Fast L, Nevola M, Martin WD, Bailey-Kellogg C, De Groot AS, et al. HCV Epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. J Hepatol 2014; pii: S0168-8278(14)00613-8.
35. Li S, Floess S, Hamann A, Gaudieri S, Lucas A, Hellard M, Roberts S, Paukovic G, Plebanski M, Loveland BE et al. Analysis of FOXP3C regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS Pathog 2009; 5(12): e1000707. Erratum in: PLoS Pathog 2012; 8(6); http://dx.doi.org/10.1371/journal.ppat.1000707
36. Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 2005; 296:1-17; PMID:16329189
37. Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; for the GBS Study Group. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf 2014. Nov;23 (11):1192-204. PMID: 24817531 http://dx.doi.org/10.1002/pds.3638
38. Li S, Jin T, Zhang HL, Yu H, Meng F, Concha Quezada H, Zhu J. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm 2014; 2014:740947; PMID:24899787
39. Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX, An P, Zhao L, Wang LH, LiQY et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70(3):410-7; PMID:21866560; http://dx.doi.org/10.1002/ana.22587